**Core Concept:** Interstitial Lung Disease (ILD) is a group of diseases that affect the lung parenchyma (air sacs) and interstitium (connective tissue surrounding the air sacs). These conditions can lead to various symptoms, including shortness of breath, cough, and chest pain. Pulmonary function tests (PFTs) are essential in diagnosing ILD, as they can assess lung function and help differentiate between various types of ILD.

**Why the Correct Answer is Right:** The correct answer, Diffusion Capacity of Carbon Monoxide (DLCO), is a crucial test in the diagnosis and management of Interstitial Lung Diseases. DLCO measures the ability of the lung to diffuse carbon monoxide from the air sacs to the bloodstream. A decrease in DLCO indicates impaired gas exchange, which is a common feature of ILDs.

**Why Each Wrong Option is Incorrect:**

A. Chest X-ray: While chest X-ray can show some features of ILD, it lacks the sensitivity and specificity to diagnose ILD accurately. DLCO is a more sensitive and specific test for ILD diagnosis.

B. High-resolution CT (HRCT): While HRCT is essential for the diagnosis of ILD, DLCO is an important test to assess the functional impact of the disease on lung function. A combination of both tests helps in accurate diagnosis and management of ILD patients.

C. Pulmonary Function Tests (PFTs): PFTs are essential in diagnosing ILD, including DLCO. However, DLCO is specifically crucial for assessing the gas exchange, which is affected in ILD.

D. Bronchoalveolar lavage (BAL): BAL is a technique used to obtain lung cells for analysis, which is not relevant to diagnose ILD. DLCO is essential in assessing gas exchange in ILD patients.

**Clinical Pearl:** The combination of HRCT and DLCO tests plays a vital role in diagnosing and managing Interstitial Lung Diseases. DLCO is crucial for assessing the functional consequences of the disease on lung function and gas exchange.